After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...